ID   ASAH2_HUMAN             Reviewed;         780 AA.
AC   Q9NR71; Q3KNU1; Q5SNT7; Q5SZP6; Q5SZP7; Q5T1D5; Q71ME6;
DT   25-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   25-JUL-2006, sequence version 2.
DT   10-MAY-2017, entry version 123.
DE   RecName: Full=Neutral ceramidase;
DE            Short=N-CDase;
DE            Short=NCDase;
DE            EC=3.5.1.23;
DE   AltName: Full=Acylsphingosine deacylase 2;
DE   AltName: Full=BCDase;
DE   AltName: Full=LCDase;
DE            Short=hCD;
DE   AltName: Full=N-acylsphingosine amidohydrolase 2;
DE   AltName: Full=Non-lysosomal ceramidase;
DE   Contains:
DE     RecName: Full=Neutral ceramidase soluble form;
GN   Name=ASAH2; Synonyms=HNAC1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=14557071; DOI=10.1016/S0378-1119(03)00721-2;
RA   Choi M.S., Anderson M.A., Zhang Z., Zimonjic D.B., Popescu N.,
RA   Mukherjee A.B.;
RT   "Neutral ceramidase gene: role in regulating ceramide-induced
RT   apoptosis.";
RL   Gene 315:113-122(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RX   PubMed=15946935; DOI=10.1074/jbc.M503002200;
RA   Osawa Y., Uchinami H., Bielawski J., Schwabe R.F., Hannun Y.A.,
RA   Brenner D.A.;
RT   "Roles for C16-ceramide and sphingosine 1-phosphate in regulating
RT   hepatocyte apoptosis in response to tumor necrosis factor-alpha.";
RL   J. Biol. Chem. 280:27879-27887(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 20-780 (ISOFORM 1), ENZYME ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, POSSIBLE SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=10781606; DOI=10.1074/jbc.M002522200;
RA   El Bawab S., Roddy P., Qian T., Bielawska A., Lemasters J.J.,
RA   Hannun Y.A.;
RT   "Molecular cloning and characterization of a human mitochondrial
RT   ceramidase.";
RL   J. Biol. Chem. 275:21508-21513(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 20-780 (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   SUBCELLULAR LOCATION, AND GLYCOSYLATION.
RX   PubMed=15845354; DOI=10.1016/j.bbrc.2005.03.134;
RA   Hwang Y.H., Tani M., Nakagawa T., Okino N., Ito M.;
RT   "Subcellular localization of human neutral ceramidase expressed in
RT   HEK293 cells.";
RL   Biochem. Biophys. Res. Commun. 331:37-42(2005).
RN   [7]
RP   FUNCTION.
RX   PubMed=16061940; DOI=10.1194/jlr.M500268-JLR200;
RA   Tani M., Sano T., Ito M., Igarashi Y.;
RT   "Mechanisms of sphingosine and sphingosine 1-phosphate generation in
RT   human platelets.";
RL   J. Lipid Res. 46:2458-2467(2005).
RN   [8]
RP   ENZYME ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, ACTIVE SITE, AND
RP   MUTAGENESIS OF SER-258; ASP-352; SER-354; CYS-362; SER-374; SER-396;
RP   SER-595 AND SER-729.
RX   PubMed=16229686; DOI=10.1042/BJ20050682;
RA   Galadari S., Wu B.X., Mao C., Roddy P., El Bawab S., Hannun Y.A.;
RT   "Identification of a novel amidase motif in neutral ceramidase.";
RL   Biochem. J. 393:687-695(2006).
RN   [9]
RP   TISSUE SPECIFICITY.
RX   PubMed=17334805; DOI=10.1007/s10048-007-0081-5;
RA   Avramopoulos D., Wang R., Valle D., Fallin M.D., Bassett S.S.;
RT   "A novel gene derived from a segmental duplication shows perturbed
RT   expression in Alzheimer's disease.";
RL   Neurogenetics 8:111-120(2007).
CC   -!- FUNCTION: Hydrolyzes the sphingolipid ceramide into sphingosine
CC       and free fatty acid at an optimal pH of 6.5-8.5. Acts as a key
CC       regulator of sphingolipid signaling metabolites by generating
CC       sphingosine at the cell surface. Acts as a repressor of apoptosis
CC       both by reducing C16-ceramide, thereby preventing ceramide-induced
CC       apoptosis, and generating sphingosine, a precursor of the
CC       antiapoptotic factor sphingosine 1-phosphate. Probably involved in
CC       the digestion of dietary sphingolipids in intestine by acting as a
CC       key enzyme for the catabolism of dietary sphingolipids and
CC       regulating the levels of bioactive sphingolipid metabolites in the
CC       intestinal tract. {ECO:0000269|PubMed:15946935,
CC       ECO:0000269|PubMed:16061940}.
CC   -!- CATALYTIC ACTIVITY: N-acylsphingosine + H(2)O = a carboxylate +
CC       sphingosine. {ECO:0000269|PubMed:10781606,
CC       ECO:0000269|PubMed:16229686}.
CC   -!- ENZYME REGULATION: Inhibited by dithiothreitol (DTT), 2-
CC       mercaptoethanol, Zn(2+), Cu(2+) and Fe(2+). Enhanced by Na(+) and
CC       Ca(2+), and at lower level Mg(2+) and Mn(2+).
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=71.4 uM for octanoyl-sphingosine
CC         {ECO:0000269|PubMed:10781606, ECO:0000269|PubMed:16229686};
CC         KM=66 uM for palmitoyl-sphingosine {ECO:0000269|PubMed:10781606,
CC         ECO:0000269|PubMed:16229686};
CC         KM=60.1 uM for D-erythro-C12-NBD-ceramide
CC         {ECO:0000269|PubMed:10781606, ECO:0000269|PubMed:16229686};
CC         Vmax=160 umol/min/mg enzyme with octanoyl-sphingosine as
CC         substrate {ECO:0000269|PubMed:10781606,
CC         ECO:0000269|PubMed:16229686};
CC         Vmax=16 umol/min/mg enzyme with palmitoyl-sphingosine as
CC         substrate {ECO:0000269|PubMed:10781606,
CC         ECO:0000269|PubMed:16229686};
CC         Vmax=0.68 nmol/min/mg enzyme with D-erythro-C12-NBD-ceramide as
CC         substrate {ECO:0000269|PubMed:10781606,
CC         ECO:0000269|PubMed:16229686};
CC       pH dependence:
CC         Optimum pH is 7.5-9.5. {ECO:0000269|PubMed:10781606,
CC         ECO:0000269|PubMed:16229686};
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15845354};
CC       Single-pass type II membrane protein
CC       {ECO:0000269|PubMed:15845354}. Note=The neutral ceramidase soluble
CC       form is a secreted protein. According to PubMed:10781606, it is
CC       mitochondrial. However, they used a shorter form in its N-
CC       terminus, which may explain this localization which probably does
CC       not exist in vivo.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NR71-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NR71-2; Sequence=VSP_019928;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Primarily expressed in the intestine
CC       (PubMed:17334805). Ubiquitously expressed with higher levels in
CC       kidney, skeletal muscle and heart (PubMed:10781606). According to
CC       PubMed:17334805, ubiquitous expression attributed to ASAH2 may be
CC       actually that of the paralog ASAH2B. {ECO:0000269|PubMed:10781606,
CC       ECO:0000269|PubMed:17334805}.
CC   -!- PTM: N-glycosylated. Required for enzyme activity (By similarity).
CC       {ECO:0000250}.
CC   -!- PTM: O-glycosylated. Required to retain it as a type II membrane
CC       protein at the cell surface. {ECO:0000269|PubMed:15845354}.
CC   -!- PTM: Phosphorylated. May prevent ubiquitination and subsequent
CC       degradation (By similarity). {ECO:0000250}.
CC   -!- PTM: Ubiquitinated, leading to its degradation by the proteasome.
CC       Ubiquitination is triggered by nitric oxid (By similarity).
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the neutral ceramidase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAL06061.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=CAI15870.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY049008; AAL06061.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AF449759; AAQ04667.2; -; mRNA.
DR   EMBL; AL450382; CAI15870.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AL589794; CAI15766.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL589794; CAI15767.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL954360; CAI17190.1; -; Genomic_DNA.
DR   EMBL; AF250847; AAF86240.1; -; mRNA.
DR   EMBL; BC107105; AAI07106.1; -; mRNA.
DR   CCDS; CCDS44398.1; -. [Q9NR71-2]
DR   CCDS; CCDS7239.2; -. [Q9NR71-1]
DR   RefSeq; NP_001137446.1; NM_001143974.1. [Q9NR71-2]
DR   RefSeq; NP_063946.2; NM_019893.2. [Q9NR71-1]
DR   RefSeq; XP_011538272.1; XM_011539970.2. [Q9NR71-1]
DR   UniGene; Hs.512645; -.
DR   PDB; 4WGK; X-ray; 2.58 A; A/B=99-780.
DR   PDBsum; 4WGK; -.
DR   ProteinModelPortal; Q9NR71; -.
DR   SMR; Q9NR71; -.
DR   STRING; 9606.ENSP00000378897; -.
DR   BindingDB; Q9NR71; -.
DR   ChEMBL; CHEMBL2021754; -.
DR   SwissLipids; SLP:000000163; -.
DR   iPTMnet; Q9NR71; -.
DR   PhosphoSitePlus; Q9NR71; -.
DR   BioMuta; ASAH2; -.
DR   DMDM; 110832757; -.
DR   MaxQB; Q9NR71; -.
DR   PaxDb; Q9NR71; -.
DR   PeptideAtlas; Q9NR71; -.
DR   PRIDE; Q9NR71; -.
DR   Ensembl; ENST00000395526; ENSP00000378897; ENSG00000188611. [Q9NR71-1]
DR   Ensembl; ENST00000447815; ENSP00000388206; ENSG00000188611. [Q9NR71-2]
DR   GeneID; 56624; -.
DR   KEGG; hsa:56624; -.
DR   UCSC; uc001jjd.4; human. [Q9NR71-1]
DR   CTD; 56624; -.
DR   DisGeNET; 56624; -.
DR   GeneCards; ASAH2; -.
DR   H-InvDB; HIX0058802; -.
DR   HGNC; HGNC:18860; ASAH2.
DR   HPA; HPA061171; -.
DR   MIM; 611202; gene.
DR   neXtProt; NX_Q9NR71; -.
DR   OpenTargets; ENSG00000188611; -.
DR   PharmGKB; PA134977109; -.
DR   eggNOG; KOG2232; Eukaryota.
DR   eggNOG; ENOG410XQWE; LUCA.
DR   GeneTree; ENSGT00390000015792; -.
DR   HOVERGEN; HBG080870; -.
DR   InParanoid; Q9NR71; -.
DR   KO; K12349; -.
DR   OMA; MGSFDIT; -.
DR   OrthoDB; EOG091G06OC; -.
DR   PhylomeDB; Q9NR71; -.
DR   TreeFam; TF300786; -.
DR   BRENDA; 3.5.1.23; 2681.
DR   Reactome; R-HSA-1660662; Glycosphingolipid metabolism.
DR   SABIO-RK; Q9NR71; -.
DR   GeneWiki; ASAH2; -.
DR   GenomeRNAi; 56624; -.
DR   PRO; PR:Q9NR71; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000188611; -.
DR   CleanEx; HS_ASAH2; -.
DR   ExpressionAtlas; Q9NR71; baseline and differential.
DR   Genevisible; Q9NR71; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005739; C:mitochondrion; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0017040; F:ceramidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0006672; P:ceramide metabolic process; TAS:ProtInc.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   InterPro; IPR006823; Ceramidase_alk.
DR   InterPro; IPR031331; NEUT/ALK_ceramidase_C.
DR   InterPro; IPR031329; NEUT/ALK_ceramidase_N.
DR   PANTHER; PTHR12670; PTHR12670; 1.
DR   Pfam; PF04734; Ceramidase_alk; 1.
DR   Pfam; PF17048; Ceramidse_alk_C; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Apoptosis; Cell membrane;
KW   Complete proteome; Glycoprotein; Hydrolase; Lipid metabolism;
KW   Membrane; Phosphoprotein; Polymorphism; Reference proteome;
KW   Signal-anchor; Sphingolipid metabolism; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   CHAIN         1    780       Neutral ceramidase.
FT                                /FTId=PRO_0000247099.
FT   CHAIN        99    780       Neutral ceramidase soluble form.
FT                                {ECO:0000250}.
FT                                /FTId=PRO_0000247100.
FT   TOPO_DOM      1     12       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     13     33       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     34    780       Lumenal. {ECO:0000255}.
FT   REGION      770    780       Required for correct folding and
FT                                localization. {ECO:0000250}.
FT   ACT_SITE    354    354       Nucleophile.
FT                                {ECO:0000269|PubMed:16229686}.
FT   CARBOHYD     62     62       O-linked (GalNAc...) threonine.
FT                                {ECO:0000255}.
FT   CARBOHYD     67     67       O-linked (GalNAc...) serine.
FT                                {ECO:0000255}.
FT   CARBOHYD     68     68       O-linked (GalNAc...) threonine.
FT                                {ECO:0000255}.
FT   CARBOHYD     70     70       O-linked (GalNAc...) threonine.
FT                                {ECO:0000255}.
FT   CARBOHYD     73     73       O-linked (GalNAc...) serine.
FT                                {ECO:0000255}.
FT   CARBOHYD     74     74       O-linked (GalNAc...) threonine.
FT                                {ECO:0000255}.
FT   CARBOHYD     76     76       O-linked (GalNAc...) threonine.
FT                                {ECO:0000255}.
FT   CARBOHYD     78     78       O-linked (GalNAc...) serine.
FT                                {ECO:0000255}.
FT   CARBOHYD     79     79       O-linked (GalNAc...) serine.
FT                                {ECO:0000255}.
FT   CARBOHYD     80     80       O-linked (GalNAc...) threonine.
FT                                {ECO:0000255}.
FT   CARBOHYD     82     82       O-linked (GalNAc...) threonine.
FT                                {ECO:0000255}.
FT   CARBOHYD     84     84       O-linked (GalNAc...) threonine.
FT                                {ECO:0000255}.
FT   CARBOHYD     98     98       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    151    151       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    217    217       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    468    468       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    564    564       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    730    730       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    779    779       O-linked (GalNAc...) threonine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     410    444       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_019928.
FT   VARIANT      51     51       T -> A (in dbSNP:rs7067625).
FT                                /FTId=VAR_027064.
FT   VARIANT     346    346       A -> S (in dbSNP:rs993869).
FT                                /FTId=VAR_027065.
FT   MUTAGEN     258    258       S->A: Impairs enzyme activity.
FT                                {ECO:0000269|PubMed:16229686}.
FT   MUTAGEN     352    352       D->A: Abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:16229686}.
FT   MUTAGEN     354    354       S->A: Abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:16229686}.
FT   MUTAGEN     362    362       C->A: Abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:16229686}.
FT   MUTAGEN     374    374       S->A: Impairs enzyme activity.
FT                                {ECO:0000269|PubMed:16229686}.
FT   MUTAGEN     396    396       S->A: No effect.
FT                                {ECO:0000269|PubMed:16229686}.
FT   MUTAGEN     595    595       S->A: Impairs enzyme activity.
FT                                {ECO:0000269|PubMed:16229686}.
FT   MUTAGEN     729    729       S->A: Impairs enzyme activity.
FT                                {ECO:0000269|PubMed:16229686}.
FT   CONFLICT    274    274       S -> P (in Ref. 1; AAL06061 and 4;
FT                                AAF86240). {ECO:0000305}.
FT   CONFLICT    602    602       T -> A (in Ref. 1; AAL06061 and 4;
FT                                AAF86240). {ECO:0000305}.
FT   CONFLICT    689    689       T -> N (in Ref. 3; CAI17190).
FT                                {ECO:0000305}.
FT   STRAND      102    110       {ECO:0000244|PDB:4WGK}.
FT   STRAND      115    123       {ECO:0000244|PDB:4WGK}.
FT   STRAND      129    135       {ECO:0000244|PDB:4WGK}.
FT   STRAND      138    145       {ECO:0000244|PDB:4WGK}.
FT   STRAND      153    161       {ECO:0000244|PDB:4WGK}.
FT   HELIX       165    179       {ECO:0000244|PDB:4WGK}.
FT   STRAND      185    192       {ECO:0000244|PDB:4WGK}.
FT   STRAND      196    199       {ECO:0000244|PDB:4WGK}.
FT   HELIX       206    212       {ECO:0000244|PDB:4WGK}.
FT   HELIX       217    235       {ECO:0000244|PDB:4WGK}.
FT   STRAND      239    249       {ECO:0000244|PDB:4WGK}.
FT   STRAND      255    257       {ECO:0000244|PDB:4WGK}.
FT   HELIX       259    262       {ECO:0000244|PDB:4WGK}.
FT   HELIX       267    270       {ECO:0000244|PDB:4WGK}.
FT   STRAND      280    288       {ECO:0000244|PDB:4WGK}.
FT   STRAND      293    299       {ECO:0000244|PDB:4WGK}.
FT   HELIX       317    330       {ECO:0000244|PDB:4WGK}.
FT   STRAND      342    346       {ECO:0000244|PDB:4WGK}.
FT   STRAND      353    355       {ECO:0000244|PDB:4WGK}.
FT   STRAND      360    362       {ECO:0000244|PDB:4WGK}.
FT   TURN        363    365       {ECO:0000244|PDB:4WGK}.
FT   TURN        377    379       {ECO:0000244|PDB:4WGK}.
FT   HELIX       380    383       {ECO:0000244|PDB:4WGK}.
FT   STRAND      384    386       {ECO:0000244|PDB:4WGK}.
FT   STRAND      389    392       {ECO:0000244|PDB:4WGK}.
FT   HELIX       393    413       {ECO:0000244|PDB:4WGK}.
FT   STRAND      417    419       {ECO:0000244|PDB:4WGK}.
FT   STRAND      423    431       {ECO:0000244|PDB:4WGK}.
FT   STRAND      436    442       {ECO:0000244|PDB:4WGK}.
FT   STRAND      444    446       {ECO:0000244|PDB:4WGK}.
FT   HELIX       454    458       {ECO:0000244|PDB:4WGK}.
FT   HELIX       478    487       {ECO:0000244|PDB:4WGK}.
FT   HELIX       493    499       {ECO:0000244|PDB:4WGK}.
FT   STRAND      504    506       {ECO:0000244|PDB:4WGK}.
FT   HELIX       508    510       {ECO:0000244|PDB:4WGK}.
FT   STRAND      513    515       {ECO:0000244|PDB:4WGK}.
FT   STRAND      520    529       {ECO:0000244|PDB:4WGK}.
FT   STRAND      532    536       {ECO:0000244|PDB:4WGK}.
FT   STRAND      538    541       {ECO:0000244|PDB:4WGK}.
FT   HELIX       543    559       {ECO:0000244|PDB:4WGK}.
FT   STRAND      566    570       {ECO:0000244|PDB:4WGK}.
FT   STRAND      572    575       {ECO:0000244|PDB:4WGK}.
FT   STRAND      578    580       {ECO:0000244|PDB:4WGK}.
FT   HELIX       583    588       {ECO:0000244|PDB:4WGK}.
FT   HELIX       591    594       {ECO:0000244|PDB:4WGK}.
FT   HELIX       602    618       {ECO:0000244|PDB:4WGK}.
FT   HELIX       622    624       {ECO:0000244|PDB:4WGK}.
FT   STRAND      658    660       {ECO:0000244|PDB:4WGK}.
FT   STRAND      664    667       {ECO:0000244|PDB:4WGK}.
FT   STRAND      670    677       {ECO:0000244|PDB:4WGK}.
FT   HELIX       681    684       {ECO:0000244|PDB:4WGK}.
FT   STRAND      693    700       {ECO:0000244|PDB:4WGK}.
FT   TURN        701    704       {ECO:0000244|PDB:4WGK}.
FT   STRAND      705    711       {ECO:0000244|PDB:4WGK}.
FT   STRAND      717    723       {ECO:0000244|PDB:4WGK}.
FT   STRAND      729    736       {ECO:0000244|PDB:4WGK}.
FT   STRAND      744    756       {ECO:0000244|PDB:4WGK}.
FT   STRAND      764    771       {ECO:0000244|PDB:4WGK}.
FT   STRAND      775    779       {ECO:0000244|PDB:4WGK}.
SQ   SEQUENCE   780 AA;  85516 MW;  D2BD7947B022A619 CRC64;
     MAKRTFSNLE TFLIFLLVMM SAITVALLSL LFITSGTIEN HKDLGGHFFS TTQSPPATQG
     STAAQRSTAT QHSTATQSST ATQTSPVPLT PESPLFQNFS GYHIGVGRAD CTGQVADINL
     MGYGKSGQNA QGILTRLYSR AFIMAEPDGS NRTVFVSIDI GMVSQRLRLE VLNRLQSKYG
     SLYRRDNVIL SGTHTHSGPA GYFQYTVFVI ASEGFSNQTF QHMVTGILKS IDIAHTNMKP
     GKIFINKGNV DGVQINRSPY SYLQNPQSER ARYSSNTDKE MIVLKMVDLN GDDLGLISWF
     AIHPVSMNNS NHLVNSDNVG YASYLLEQEK NKGYLPGQGP FVAAFASSNL GDVSPNILGP
     RCINTGESCD NANSTCPIGG PSMCIAKGPG QDMFDSTQII GRAMYQRAKE LYASASQEVT
     GPLASAHQWV DMTDVTVWLN STHASKTCKP ALGYSFAAGT IDGVGGLNFT QGKTEGDPFW
     DTIRDQILGK PSEEIKECHK PKPILLHTGE LSKPHPWHPD IVDVQIITLG SLAITAIPGE
     FTTMSGRRLR EAVQAEFASH GMQNMTVVIS GLCNVYTHYI TTYEEYQAQR YEAASTIYGP
     HTLSAYIQLF RNLAKAIATD TVANLSRGPE PPFFKQLIVP LIPSIVDRAP KGRTFGDVLQ
     PAKPEYRVGE VAEVIFVGAN PKNSVQNQTH QTFLTVEKYE ATSTSWQIVC NDASWETRFY
     WHKGLLGLSN ATVEWHIPDT AQPGIYRIRY FGHNRKQDIL KPAVILSFEG TSPAFEVVTI
//
